Work for Prevail Therapeutics Inc.?

Claim Your Profile

Prevail Therapeutics Inc. Logo Image

Prevail Therapeutics Inc.

Prevail Therapeutics Inc. Banner Image

Most Recent Annual Report

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

2019 Annual Report and Form 10K

Prevail Therapeutics Inc.

Prevail Therapeutics Inc. has reached its limit for free report views.

About Prevail Therapeutics Inc.

1-10 Employees
Based in New York City, New York

Prevail is a gene therapy company leveraging breakthroughs in human genetics with the goal of developing and commercializing disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases. The Company is developing PR001 for patients with Parkinson’s disease with GBA1 mutations (PD-GBA) and neuronopathic Gaucher disease; PR006 for patients with frontotemporal dementia with GRN mutations (FTD-GRN); and PR004 for patients with certain synucleinopathies.

Ticker:
PRVL
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol